90 related articles for article (PubMed ID: 21645611)
1. Nimesulide interaction with membrane model systems: are membrane physical effects involved in nimesulide mitochondrial toxicity?
Monteiro JP; Martins AF; Lúcio M; Reis S; Pinheiro TJ; Geraldes CF; Oliveira PJ; Jurado AS
Toxicol In Vitro; 2011 Sep; 25(6):1215-23. PubMed ID: 21645611
[TBL] [Abstract][Full Text] [Related]
2. A biophysical approach to menadione membrane interactions: relevance for menadione-induced mitochondria dysfunction and related deleterious/therapeutic effects.
Monteiro JP; Martins AF; Nunes C; Morais CM; Lúcio M; Reis S; Pinheiro TJ; Geraldes CF; Oliveira PJ; Jurado AS
Biochim Biophys Acta; 2013 Aug; 1828(8):1899-908. PubMed ID: 23590997
[TBL] [Abstract][Full Text] [Related]
3. Unaltered hepatic oxidative phosphorylation and mitochondrial permeability transition in wistar rats treated with nimesulide: Relevance for nimesulide toxicity characterization.
Moreno AJ; Oliveira PJ; Nova CD; Alvaro AR; Moreira RA; Santos SM; Macedo T
J Biochem Mol Toxicol; 2007; 21(2):53-61. PubMed ID: 17427176
[TBL] [Abstract][Full Text] [Related]
4. Drug permeability across a phospholipid vesicle based barrier: 3. Characterization of drug-membrane interactions and the effect of agitation on the barrier integrity and on the permeability.
Flaten GE; Skar M; Luthman K; Brandl M
Eur J Pharm Sci; 2007 Mar; 30(3-4):324-32. PubMed ID: 17204409
[TBL] [Abstract][Full Text] [Related]
5. Relevance of lipid polar headgroups on boron-mediated changes in membrane physical properties.
Verstraeten SV; Lanoue L; Keen CL; Oteiza PI
Arch Biochem Biophys; 2005 Jun; 438(1):103-10. PubMed ID: 15882836
[TBL] [Abstract][Full Text] [Related]
6. Effects of lipid chain length on molecular interactions between paclitaxel and phospholipid within model biomembranes.
Zhao L; Feng SS
J Colloid Interface Sci; 2004 Jun; 274(1):55-68. PubMed ID: 15120278
[TBL] [Abstract][Full Text] [Related]
7. The anti-inflammatory drug, nimesulide (4-nitro-2-phenoxymethane-sulfoanilide), uncouples mitochondria and induces mitochondrial permeability transition in human hepatoma cells: protection by albumin.
Berson A; Cazanave S; Descatoire V; Tinel M; Grodet A; Wolf C; Feldmann G; Pessayre D
J Pharmacol Exp Ther; 2006 Jul; 318(1):444-54. PubMed ID: 16617166
[TBL] [Abstract][Full Text] [Related]
8. Effects of lipid chain unsaturation and headgroup type on molecular interactions between paclitaxel and phospholipid within model biomembrane.
Zhao L; Feng SS
J Colloid Interface Sci; 2005 May; 285(1):326-35. PubMed ID: 15797430
[TBL] [Abstract][Full Text] [Related]
9. Nimesulide aggravates redox imbalance and calcium dependent mitochondrial permeability transition leading to dysfunction in vitro.
Singh BK; Tripathi M; Pandey PK; Kakkar P
Toxicology; 2010 Sep; 275(1-3):1-9. PubMed ID: 20457212
[TBL] [Abstract][Full Text] [Related]
10. Permeability and stability properties of membranes formed by lipids extracted from Lactobacillus acidophilus grown at different temperatures.
Fernández Murga ML; Bernik D; Font de Valdez G; Disalvo AE
Arch Biochem Biophys; 1999 Apr; 364(1):115-21. PubMed ID: 10087172
[TBL] [Abstract][Full Text] [Related]
11. Destabilizing effects of fructose-1,6-bisphosphate on membrane bilayers.
Ehringer WD; Su S; Chiangb B; Stillwell W; Chien S
Lipids; 2002 Sep; 37(9):885-92. PubMed ID: 12458624
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial permeability transition as a source of superoxide anion induced by the nitroaromatic drug nimesulide in vitro.
Tay VK; Wang AS; Leow KY; Ong MM; Wong KP; Boelsterli UA
Free Radic Biol Med; 2005 Oct; 39(7):949-59. PubMed ID: 16140214
[TBL] [Abstract][Full Text] [Related]
13. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
14. The anionic phospholipid-mediated membrane interaction of the anti-cancer drug doxorubicin is enhanced by phosphatidylethanolamine compared to other zwitterionic phospholipids.
Speelmans G; Staffhorst RWHM ; de Kruijff B
Biochemistry; 1997 Jul; 36(28):8657-62. PubMed ID: 9214313
[TBL] [Abstract][Full Text] [Related]
15. Salicylic acid-induced effects in the mixed-lipid (dipalmitoyl phosphatidylcholine-dipalmitoyl phosphatidylethanolamine) model membrane.
Panicker L; Mishra KP
J Colloid Interface Sci; 2005 Oct; 290(1):250-8. PubMed ID: 15964011
[TBL] [Abstract][Full Text] [Related]
16. Configuration of polyisoprenoids affects the permeability and thermotropic properties of phospholipid/polyisoprenoid model membranes.
Ciepichal E; Jemiola-Rzeminska M; Hertel J; Swiezewska E; Strzalka K
Chem Phys Lipids; 2011 May; 164(4):300-6. PubMed ID: 21440533
[TBL] [Abstract][Full Text] [Related]
17. Interlamellar coupling of phospholipid bilayers in liposomes: an emergent property of lipid rearrangement.
Parry MJ; Hagen M; Mouritsen OG; Kinnunen PK; Alakoskela JM
Langmuir; 2010 Apr; 26(7):4909-15. PubMed ID: 20180577
[TBL] [Abstract][Full Text] [Related]
18. Ethylazinphos interaction with membrane lipid organization induces increase of proton permeability and impairment of mitochondrial bioenergetic functions.
Videira RA; Antunes-Madeira MC; Madeira VM
Toxicol Appl Pharmacol; 2001 Sep; 175(3):209-16. PubMed ID: 11559019
[TBL] [Abstract][Full Text] [Related]
19. Phospholipid acyl chain rotational dynamics are independent of headgroup structure in unilamellar vesicles containing binary mixtures of dioleoyl-phosphatidylcholine and dioleoyl-phosphatidylethanolamine.
Hunter GW; Squier TC
Biochim Biophys Acta; 1998 Dec; 1415(1):63-76. PubMed ID: 9858687
[TBL] [Abstract][Full Text] [Related]
20. NSAIDs interactions with membranes: a biophysical approach.
Nunes C; Brezesinski G; Pereira-Leite C; Lima JL; Reis S; Lúcio M
Langmuir; 2011 Sep; 27(17):10847-58. PubMed ID: 21790169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
